CASTLE BIOSCIENCES, INC. (CSTL) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $2.92M; Long-term Debt, Excluding Current MaturitiesUSD $7.16M; Long-term DebtUSD $10.07M; Long-term Debt, GrossUSD $10.20M.
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $1.67M; Long-term Debt, Excluding Current MaturitiesUSD $8.40M; Long-term DebtUSD $10.07M; Long-term Debt, GrossUSD $10.20M.
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $417.00K; Long-term Debt, Excluding Current MaturitiesUSD $9.64M; Long-term DebtUSD $10.06M; Long-term Debt, GrossUSD $10.20M.
- 2025-09-30: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $10.05M; Long-term DebtUSD $10.05M; Long-term Debt, GrossUSD $10.20M.
CASTLE BIOSCIENCES, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-term Debt, Gross USD | Debt Instrument, Fair Value Disclosure USD | Debt Instrument, Unamortized Discount USD | Short-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Notes Payable, Related Parties, Current USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.92M | $7.16M | $10.07M | $10.20M | $10.07M | $125.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $1.67M | $8.40M | $10.07M | $10.20M | $10.07M | $134.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $417.00K | $9.64M | $10.06M | $10.20M | $10.06M | $143.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $10.05M | $10.05M | $10.20M | (m) | $151.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $1.94M | $8.10M | $10.04M | $10.20M | (m) | $160.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $1.11M | $8.92M | $10.03M | $10.20M | (m) | $168.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $278.00K | $9.74M | $10.02M | $10.20M | (m) | $177.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $10.02M | $10.02M | $10.20M | (m) | $185.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $10.01M | $10.01M | $10.20M | (m) | $192.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $10.00M | $10.00M | $10.20M | (m) | $200.00K | (m) | $278.00K | $3.33M | $3.33M | $3.06M | (m) | $0.00 | (m) |
| 2023-12-31 | $0.00 | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $10.00M | $12.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $10.00M | $14.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $8.33M | $17.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $5.83M | $19.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | $26.69M | (m) | (m) | (m) | (m) | $5.83M | $10.00M | $10.86M | $0.00 | $0.00 | (m) | (m) |
| 2019-09-30 | $3.33M | $21.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $833.33K | $23.86M | (m) | (m) | (m) | (m) | $4.43M | (m) | (m) | (m) | (m) | (m) | (m) | $4.76M |
| 2018-12-31 | $0.00 | $24.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |